Search Results 71-80 of 9667 for TNF
Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Related Articles. Top 10 questions about breast cancer answered featured image.
... TNF-biologic. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
CAPS is a rare, inherited disease of the immune system. Canakinumab injection is also used to treat tumor necrosis factor receptor associated periodic syndrome ...
Also known as biologic response modifiers, this newer class of drugs includes tumor necrosis factor (TNF) blockers, such as etanercept (Enbrel, Erelzi ...
Has had previous treatment with tumor necrosis factor- alpha (TNF-alpha) antagonists without documented clinical response to treatment (example, due to lack ...
Two are the tumor necrosis factor inhibitors adalimumab, or Humira, and infliximab, or Remicade. These medicines work by dampening part of the immune system ...
... tumor necrosis factor (TNF) is important in the formation of granulomas. In this study, we assessed therapy with anti-TNF agents in patients with TA that ...
... TNF alpha agents. Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) Rochester, MN. The purpose of this study is to ...
TNF-inhibitors; Methotrexate; IL-1Ra antagonist. Women who are pregnant or nursing; Elect not to provide peripheral blood draw. Cohort 2: History of ipsilateral ...
... Tumor Necrosis-Factor-Alpha Therapy (anti-TNF α) agent; Effective contraception from screening and for 36 weeks after the last dose of investigational ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.